Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Taste Disorders 1 Parasomnias 1 Pain 1 Olfaction Disorders 1 Neoplasms 1 Nausea 1 Marijuana Abuse 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Cancer Pain 1 Breast Neoplasms 1 Anxiety Disorders 1 Anorexia 1

Interventions

Morphine 2 resiniferatoxin 1 incobotulinumtoxinA 1 fulranumab 1 cannabichromene 1 alvimopan 1 Tablets 1 Surveys and Questionnaires 1 Standard of Care 1 Pain Management 1 Oxycodone 1 Occupational Therapy 1 Massage 1 Lidocaine 1 Lenalidomide 1 Ketamine 1 Gels 1 Fentanyl 1 Dronabinol 1 Cannabidiol 1 Animal Assisted Therapy 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cancer Pain × Dronabinol × Clear all

NCT06533657 2026-04-21

UTOPIA-1

ZYUS Life Sciences Inc.

Phase 2 Completed

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡